Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients.
Bardini
M
M
Galbiati
M
M
Lettieri
A
A
Bungaro
S
S
Gorletta
T A
TA
Biondi
A
A
Cazzaniga
G
G